Unlocking the full patient journey—from diagnosis to treatment—is critical for developing more effective therapies. The panel will dive into how real-world data (RWD) can illuminate hidden gaps in care using non-small cell lung cancer (NSCLC) as a powerful example.
MedCity INVEST Digital Health on September 18 at Pegasus Park in Dallas will explore AI through a series of discussions leading up to our annual Pitch Perfect contest, where healthcare startups pitch their companies to a team of investor judges. Register today!
Kura Oncology's ziftomenib addresses a specific genetic mutation present in about 30% of cases of acute myeloid leukemia. Data from the drug's pivotal Phase 2 test were presented during the annual meeting of the American Society of Clinical Oncology.
This is the moment to build flexible plans. Organizations that develop operational models with built-in scenario planning, ready to scale up or down as the capital environment shifts, will be positioned to take advantage of greater investment when it comes.
The combination of coverage awareness and care navigation powered by agentic AI has the potential to transform how older adults engage with the healthcare system.
At MedCity INVEST, Shawn Gremminger, president and CEO of the National Alliance of Healthcare Purchaser Coalitions, discussed the strategies he's seeing employers implement around GLP-1s.
He noted that many employers are taking a "middle ground" approach—such as covering the drugs for individuals with higher BMIs—and are also providing lifestyle support.
Radiologists today face a surge in imaging volume and pressure to produce fast, accurate reports. Workflow optimization is about delivering the right results at the right time with less friction.
In this episode of the MedCity Pivot Podcast, editor-in-chief Arundhati Parmar, speaks with Helix CEO James Lu about his company and how far precision medicine has come.
No comments